A patient-driven registry on Behçet's disease: the AIDA for patients pilot project.
Behçet’s disease
autoinflammatory diseases
patient involvement
patient-driven registries
patient-reported outcomes
rare diseases
Journal
Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047
Informations de publication
Date de publication:
2023
2023
Historique:
received:
16
03
2023
accepted:
22
05
2023
medline:
3
7
2023
pubmed:
3
7
2023
entrez:
3
7
2023
Statut:
epublish
Résumé
This paper describes the creation and preliminary results of a patient-driven registry for the collection of patient-reported outcomes (PROs) and patient-reported experiences (PREs) in Behçet's disease (BD). The project was coordinated by the University of Siena and the Italian patient advocacy organization SIMBA (Associazione Italiana Sindrome e Malattia di Behçet), in the context of the AIDA (AutoInflammatory Diseases Alliance) Network programme. Quality of life, fatigue, socioeconomic impact of the disease and therapeutic adherence were selected as core domains to include in the registry. Respondents were reached via SIMBA communication channels in 167 cases (83.5%) and the AIDA Network affiliated clinical centers in 33 cases (16.5%). The median value of the Behçet's Disease Quality of Life (BDQoL) score was 14 (IQR 11, range 0-30), indicating a medium quality of life, and the median Global Fatigue Index (GFI) was 38.7 (IQR 10.9, range 1-50), expressing a significant level of fatigue. The mean Beliefs about Medicines Questionnaire (BMQ) necessity-concern differential was 0.9 ± 1.1 (range - 1.8-4), showing that the registry participants prioritized necessity belief over concerns to a limited extent. As for the socioeconomic impact of BD, in 104 out of 187 cases (55.6%), patients had to pay from their own pocket for medical exams required to reach the diagnosis. The low family socioeconomic status ( Preliminary results from the AIDA for Patients BD registry were consistent with data available in the literature, confirming that PROs and PREs could be easily provided by the patient remotely to integrate physician-driven registries with complementary and reliable information.
Identifiants
pubmed: 37396916
doi: 10.3389/fmed.2023.1188021
pmc: PMC10313381
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1188021Informations de copyright
Copyright © 2023 Gaggiano, Del Bianco, Sota, Gentileschi, Ruscitti, Giacomelli, Piga, Crisafulli, Monti, Emmi, De Paulis, Vitale, Tarsia, Caggiano, Nuzzolese, Parretti, Fabiani, Lopalco, Maier, Cattalini, Rigante, Govoni, Li Gobbi, Guiducci, Parronchi, Marino, Ciccia, Maggio, Aragona, Bartoloni, Iagnocco, Viapiana, Sebastiani, Guerriero, Insalaco, Del Giudice, Conti, Barone, Olivieri, Brucato, Carubbi, Triggianese, Mauro, Tosi, Fonollosa, Giardini, Ragab, Tharwat, Hernández-Rodríguez, Sfikakis, Laskari, Karamanakos, Espinosa, Shahram, Direskeneli, Hinojosa-Azaola, Opris-Belinski, AlMaghlouth, Hatemi, Eksin, Önen, Więsik-Szewczyk, Akkoç, Tufan, Şahin, Erten, Ozen, Batu, Frediani, Balistreri and Cantarini.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Arthritis Care Res (Hoboken). 2022 Apr;74(4):691-699
pubmed: 33202101
Front Med (Lausanne). 2022 Dec 05;9:996571
pubmed: 36544503
Clin Exp Rheumatol. 2018 Nov-Dec;36(6 Suppl 115):135-140
pubmed: 29998839
Intern Emerg Med. 2017 Oct;12(7):947-955
pubmed: 28620840
Clin Rheumatol. 2006 May;25(3):329-33
pubmed: 16267609
Clin Exp Rheumatol. 2021 Sep-Oct;39 Suppl 132(5):88-93
pubmed: 34596034
J Epidemiol Community Health. 2003 Jan;57(1):68-73
pubmed: 12490652
Caspian J Intern Med. 2022 Summer;13(3):447-457
pubmed: 35974926
Int J Environ Res Public Health. 2018 Aug 03;15(8):
pubmed: 30081484
Arthritis Res Ther. 2021 Aug 30;23(1):224
pubmed: 34461986
Scand J Rheumatol. 2021 Nov;50(6):475-478
pubmed: 33827364
Mod Rheumatol. 2019 Nov;29(6):1023-1030
pubmed: 30557064
J Rheumatol. 2004 May;31(5):931-7
pubmed: 15124253
J Nurs Meas. 2018 Apr 1;26(1):36-75
pubmed: 29724278
Int J Rheum Dis. 2018 Dec;21(12):2158-2166
pubmed: 28627044
Med Care. 1999 Feb;37(2):126-39
pubmed: 10024117
Clin Immunol. 2023 Jan;246:109186
pubmed: 36410686
Clin Rheumatol. 2019 Mar;38(3):761-768
pubmed: 30367312
Pharm Pract (Granada). 2016 Jan-Mar;14(1):708
pubmed: 27011778
Scand J Rheumatol. 2022 Jan;51(1):50-58
pubmed: 34121600
Clin Exp Rheumatol. 2022 Sep;40(8):1461-1471
pubmed: 35894066
Eur J Rheumatol. 2021 Oct;8(4):211-216
pubmed: 35110181
Int J Rheum Dis. 2016 Jan;19(1):95-103
pubmed: 26258691
Chronic Illn. 2009 Jun;5(2):129-33
pubmed: 19474235
Ann Rheum Dis. 2016 Jun;75(6):958-64
pubmed: 26698843